Skip to main content

Management of Adult with Childhood-Onset Growth Hormone Deficiency

  • Chapter
  • First Online:
  • 2643 Accesses

Part of the book series: Contemporary Endocrinology ((COE))

Abstract

The patient with childhood-onset growth hormone deficiency (COGHD) with growth as the major endpoint of therapy during childhood presents a number of diagnostic and therapeutic challenges once the pediatric indication for treatment ends. This period of going from the pediatric indication to the adult indication has been referred to as the transition period. Not all children entering the transition period remain persistently growth hormone deficient (GHD). These are predominantly in the “idiopathic” COGHD category, while the patients with severe pituitary damage represent the patients who almost always remain GH deficient. Preparation for diagnosing and treating these patients is the subject of this report. The stage for informing the patient and his or her family must remain with the pediatrician taking care of the patient during the pediatric treatment period. “Transitioning” the patient to the adult indication requires consultation even before the pediatric indication is completed so that the patient and family can come to an informed decision to continue or discontinue GH therapy.

This is a preview of subscription content, log in via an institution.

Buying options

Chapter
USD   29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD   189.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Hardcover Book
USD   249.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Learn about institutional subscriptions

References

  1. Attanasio AF, Lamberts SW, Matranga AM, et al. Adult Growth Hormone Deficiency Study Group. Adult growth hormone (GH)-deficient patients demonstrate heterogeneity between childhood onset and adult onset before and during human GH treatment. J Clin Endocrinol Metab. 1997;82:82–8.

    Article  CAS  PubMed  Google Scholar 

  2. Ogle GD, Moore B, Lu PW, Craighead A, Briody JN, Cowell CT. Changes in body composition and bone density after discontinuation of growth hormone therapy in adolescence: an interim report. Acta Paediatr Suppl. 1994;399:3–7 [discussion 8].

    Article  CAS  PubMed  Google Scholar 

  3. Johannsson G, Albertsson-Wikland K, Bengtsson BA. Swedish Study Group for Growth Hormone Treatment in Children. Discontinuation of growth hormone (GH) treatment: metabolic effects in GH-deficient and GH-sufficient adolescent patients compared with ­control subjects. J Clin Endocrinol Metab. 1999;84: 4516–24.

    Article  CAS  PubMed  Google Scholar 

  4. Longobardi S, Cuocolo A, Merola B, et al. Left ventricular function in young adults with childhood and adulthood onset growth hormone deficiency. Clin Endocrinol (Oxf). 1998;48:137–43.

    Article  CAS  Google Scholar 

  5. Cummings DE, Merriam GR. Growth hormone therapy in adults. Annu Rev Med. 2003;54:513–33.

    Article  CAS  PubMed  Google Scholar 

  6. Kelly DF, Gonzalo IT, Cohan P, Berman N, Swerdloff R, Wang C. Hypopituitarism following traumatic brain injury and aneurysmal subarachnoid hemorrhage: a preliminary report. J Neurosurg. 2000;93: 743–52.

    Article  CAS  PubMed  Google Scholar 

  7. Lieberman SA, Oberoi AL, Gilkison CR, Masel BE, Urban RJ. Prevalence of neuroendocrine dysfunction in patients recovering from traumatic brain injury. J Clin Endocrinol Metab. 2001;86:2752–6.

    Article  CAS  PubMed  Google Scholar 

  8. Aimaretti G, Ambrosio MR, Di Somma C, et al. Residual pituitary function after brain injury-induced hypopituitarism: a prospective 12-month study. J Clin Endocrinol Metab. 2005;90:6085–92.

    Article  CAS  PubMed  Google Scholar 

  9. Aimaretti G, Ambrosio MR, Di Somma C, et al. Traumatic brain injury and subarachnoid haemorrhage are conditions at high risk for hypopituitarism: screening study at 3 months after the brain injury. Clin Endocrinol (Oxf). 2004;61:320–6.

    Article  CAS  Google Scholar 

  10. Kreitschmann-Andermahr I, Hoff C, Saller B, et al. Prevalence of pituitary deficiency in patients after aneurysmal subarachnoid hemorrhage. J Clin Endocrinol Metab. 2004;89:4986–92.

    Article  CAS  PubMed  Google Scholar 

  11. August GP, et al. J Peds. 1990;116:899.

    Article  CAS  Google Scholar 

  12. Clayton PE, Cuneo RC, Juul A, Monson JP, Shalet SM, Tauber M. Consensus statement on the management of the GH-treated adolescent in the transition to adult care. Eur J Endocrinol. 2005;152:165–70.

    Article  CAS  PubMed  Google Scholar 

  13. Molitch M, Clemmons DR, Malozowski S, Merriam GR, Shalet SM, Vance ML for The Endocrine Society’s Clinical Guidelines Subcommittee. Evaluation and treatment of adult growth hormone deficiency: an endocrine society clinical practice guideline. J Clin Endocrinol Metab 2006;91:1621–34.

    Google Scholar 

  14. Ho KK. Consensus guidelines for the diagnosis and treatment of adults with GH deficiency II: a statement of the GH Research Society in association with the European Society for Pediatric Endocrinology, Lawson Wilkins Society, European Society of Endocrinology, Japan Endocrine Society, and Endocrine Society of Australia. Eur J Endocrinol. 2007;157:695–700.

    Article  CAS  PubMed  Google Scholar 

  15. Cook DM, Yuen KC, Biller BM, Kemp SF, Vance ML. American association of clinical endocrinologists medical guidelines for clinical practice for growth hormone use in growth hormone-deficient adults and transition patients—2009 update: executive summary of recommendations. End Prac. 2009; 15:580–6.

    Google Scholar 

  16. Brabant G, Poll EM, Jönsson P, Polydorou D, Kreitschmann-Andermahr I. Etiology, baseline characteristics, and biochemical diagnosis of GH deficiency in the adult: are there regional variations? Eur J Endocrinol. 2009;161 Suppl 1:S25–31.

    Article  CAS  PubMed  Google Scholar 

  17. Hartman ML, Crowe BJ, Biller BM, et al. Which patients do not require a GH stimulation test for the diagnosis of adult GH deficiency? J Clin Endocrinol Metab. 2002;87(2):477–85.

    Article  CAS  PubMed  Google Scholar 

  18. DeBoer H, van der Veen EA. Why retest young adults with childhood-onset growth hormone deficiency. J Clin Endocrinol Metab. 1997;82:2032–6.

    Article  CAS  Google Scholar 

  19. Nicolson A, Toogood A, Rahim A, et al. The prevalence of severe growth hormone deficiency in adults who received growth hormone replacement in childhood. Clin Endocrinol. 1996;44:311–6.

    Article  CAS  Google Scholar 

  20. Conceicao FL, da Costa e Silva A, Leal Costa AJ, Vaisman M. Glucagon stimulation test for the diagnosis of GH deficiency in adults. J Endocrinol Invest. 2003;26:1065–70.

    CAS  PubMed  Google Scholar 

  21. Gomez JM, Espadero RM, Escobar-Jimenez F, et al. Growth hormone release after glucagon as a reliable test of growth hormone assessment in adults. Clin Endocrinol (Oxf). 2002;56:329–34.

    Article  CAS  Google Scholar 

  22. Wacharasindhu S, Cotterill AM, Camacho-Hubner C, et al. Normal growth hormone secretion in growth hormone insufficient children retested after completion of linear growth. Clin Endocrinol. 1996;45: 553–6.

    Article  CAS  Google Scholar 

  23. Maghnie M, Strigazzi C, Tinelli C, et al. Growth ­hormone (GH) deficiency (GHD) of childhood onset: reassessment of GH status and evaluation of the predictive criteria for permanent GHD in young adults. J Clin Endocrinol Metab. 1999;84:1324–8.

    Article  CAS  PubMed  Google Scholar 

  24. Saggese G, Baroncelli G, Bertelloni S, et al. The effect of long-term growth hormone (GH) treatment on bone mineral density in children with GH deficiency. Role of GH in the attainment of peak bone mass. J Clin Endocrinol Metab. 1996;81:3077–83.

    Article  CAS  PubMed  Google Scholar 

  25. DeBoer H, Blok G, Van Lingen A, et al. Consequences of childhood-onset growth hormone deficiency for adult bone mass. J Bone Miner Res. 1994;9: 1319–22.

    Article  CAS  Google Scholar 

  26. Ter Maaten J, DeBoer H, Kamp O, et al. Long-term effects of growth hormone (GH) replacement in men with childhood-onset GH deficiency. J Clin Endocrinol Metab. 1999;84:2373–80.

    Article  PubMed  Google Scholar 

  27. Kaufman JM, Taelman P, Vermeulen A, et al. Bone mineral status in growth hormone-deficient males with isolated and multiple pituitary deficiencies of childhood onset. J Clin Endocrinol Metab. 1992;74: 118–23.

    Article  CAS  PubMed  Google Scholar 

  28. Baroncelli G, Bertelloni S, Ceccarelli C, et al. Measurement of volumetric bone mineral density accurately determines degree of lumbar undermineralization in children with growth hormone deficiency. J Clin Endocrinol Metab. 1998;83:3150–4.

    Article  CAS  PubMed  Google Scholar 

  29. Wiren R, Wilhelmsen L, Wiklund I, et al. Decreased psychological well-being in adult patients with growth hormone deficiency. J Clin Endocrinol. 1994;40: 111–6.

    Article  Google Scholar 

  30. Gartorio A, Molinari P, Grugni G, et al. The psychosocial outcome of adults with growth hormone deficiency. Acta Med Auxol. 1986;18:123–8.

    Google Scholar 

  31. Burman P, Broman JE, Hetta J, et al. Quality of life in adults with growth hormone (GH) deficiency: response to treatment with recombinant human GH in a placebo-controlled 21-month trial. J Clin Endocrinol Metab. 1995;80:3585–90.

    Article  CAS  PubMed  Google Scholar 

  32. Leger J, Danner S, Simon D, Garel C, Czernichow P. Do all patients with childhood-onset growth hormone deficiency (GHD) and ectopic neurohypophysis have persistent GHD in adulthood? J Clin Endocrinol Metab. 2005;90:650–6.

    Article  CAS  PubMed  Google Scholar 

  33. di Iorgi N, Secco A, Napoli F, et al. Deterioration of growth hormone response and anterior pituitary function in young adults with childhood-onset GH deficiency and ectopic posterior pituitary: a two-year prospective follow-up study. J Clin Endocrinol Metab. 2007;92:3875–84.

    Article  PubMed  Google Scholar 

  34. Yuen KC, Cook DM, Rumbaugh EE, Cook MB, Dunger DB. Individual IGF-I responsiveness to a fixed regimen of low-dose growth hormone replacement is increased with less variability in obese compared to non-obese adults with severe growth hormone deficiency. Horm Res. 2006;65:6–13.

    Article  CAS  PubMed  Google Scholar 

  35. Yuen KC, Cook DM, Ong K, et al. The metabolic effects of short-term administration of physiological versus high doses of GH therapy in GH deficient adults. Clin Endocrinol (Oxf). 2002;57:333–41.

    Article  CAS  Google Scholar 

  36. Hyer SL, Rodin DA, Tobias JH, Leiper A, Nussey SS. Growth hormone deficiency during puberty reduces adult bone mineral density. Arch Dis Child. 1992;67:1472–4.

    Article  CAS  PubMed  Google Scholar 

  37. Kaufman JM, Taelman P, Vermeulen A, Vandeweghe M. Bone mineral status in growth hormone-deficient males with isolated and multiple pituitary deficiencies of childhood onset. J Clin Endocrinol Metab. 1992; 74:118–23.

    Article  CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to David Michael Cook M.D., B.S. .

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 2013 Springer Science+Business Media New York

About this chapter

Cite this chapter

Cook, D.M. (2013). Management of Adult with Childhood-Onset Growth Hormone Deficiency. In: Radovick, S., MacGillivray, M. (eds) Pediatric Endocrinology. Contemporary Endocrinology. Humana Press, Totowa, NJ. https://doi.org/10.1007/978-1-60761-395-4_8

Download citation

  • DOI: https://doi.org/10.1007/978-1-60761-395-4_8

  • Published:

  • Publisher Name: Humana Press, Totowa, NJ

  • Print ISBN: 978-1-60761-394-7

  • Online ISBN: 978-1-60761-395-4

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics